Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Makes Policy Waves With Pullback Of Longstanding TENS Coverage

This article was originally published in The Gray Sheet

Executive Summary

The new finalized coverage policy for transcutaneous electrical nerve stimulation for treating chronic back pain is a rare decision by the agency to reverse coverage on an established technology, and is a new direction for the coverage-with-evidence-development program, observers say.

Advertisement

Related Content

Medtech Tools To Help Address Opioid Crisis Face Reimbursement Challenges
New Coverage-With-Evidence-Development Guidance In The Works Following MedCAC Meeting
Groups Pained By CMS’ Use Of Coverage With Evidence Development In TENS Proposal
CMS Obesity Coverage Proposal Includes Sunset Deadlines For CED Studies
CMS Proposal Would Narrow Longstanding Coverage Of TENS For Back Pain
CMS Offers Two Paths To “Coverage With Evidence” In Revised Guidance

Topics

Advertisement
UsernamePublicRestriction

Register

MT031304

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel